Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Sickle cell trait and cognitive function in African Americans: The reasons for geographic and racial differences in stroke (REGARDS) cohort
source: American Society of Hematology
year: 2017
authors: Mary Cushman, Justin M Leach, Christina Cahill, Leslie A McClure, Marguerite Ryan Irvin, Neil A Zakai, Rakhi P. Naik, Frederick Unverzagt, Virginia Wadley, Hyacinth I Hyacinth, Suzanne E Judd, Jennifer Manly
summary/abstract:Sickle cell anaemia (SCA) has been associated with cognitive dysfunction. Increasing evidence suggests that some complications of SCA, such as kidney disease and venous thromboembolism, also affect those with sickle cell trait (SCT). Thus, SCT may not be a benign condition. Based on these findings, we hypothesized that SCT is a risk factor for cognitive function in African-Americans. We previously reported no association of SCT with cognitive impairment evaluated by a global screening test. Here we studied specific cognitive function measures.
Methods: We studied African-American adults aged 45 and older from a national prospective cohort study of 30,239 white and black Americans; the REGARDS study. Participants were enrolled in 2003-7 and followed for up to 10 years. We collected extensive baseline risk factor data, and administered a cognitive battery every 2 years including tests of learning and memory (Word List Learning (WLL), Word List Recall (WLR)), semantic fluency by the Animal Naming test, and phonemic fluency by the Letter F test. WLL is the sum of words learned over 3 trials of immediate recall of 10 words (score ranges 0-30 words). WLR is the sum of words recalled after intervening questions (range 0-10 words). The Animal Naming score is the number of animals a participant can name within 1-minute and the Letter F score is the number of words beginning with the letter F that a participant can say within 1-minute. Participants included in this analysis were African-Americans without SCA or prebaseline stroke, who had SCT genotyping. Participants with baseline cognitive impairment by a global screening test were excluded. Mixed models were employed to assess the association of SCT with repeated measures of each test, adjusted for risk factors. Censoring occurred at the time of a stroke, death or withdrawal from the study.
Results: There were 7,078 participants with at least 1 assessment of WLL and WLR who met inclusion criteria; their mean age was 63.4 years, 64% were women, and 517 had SCT. Those with SCT were more likely than those without to have hypertension (65% vs 60%; p=0.04), no alcohol use (75% vs 70%, p=0.03), and lower estimated glomerular filtration rate (eGFR) (86 vs 90 ml/min/1.73m2; p<0.0001). They were similar on other factors. The top panel of the figure shows that WLL and WLR changed little over time and there was no difference in scores by SCT status (adjusted p values shown). There were 7,296 participants included in the Animal Naming analysis and 5,946 for Letter F (differences due to delays in processing scores). The lower panel of the figure shows that performance on both tests worsened over time, with no difference by SCT status (adjusted p values shown).
organization: Larner College of Medicine at the University of Vermont, Colchester, VT; University of Alabama at Birmingham, Birmingham, AL; Drexel University, Philadelphia, PA; Johns Hopkins University School of Medicine, Baltimore, MD; Indiana University School of Medicine, Indianapolis, IN; Emory University, Atlanta, GA; Columbia University, New Yorkread more
+myBinderRelated Content
-
Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH ...Background: Sickle cell anemia (SCA) i...
-
Newborn screening for sickle cell disease in Europe: Recommendations from a Pan-European Consensus ConferenceSickle Cell Disease (SCD) is an increasi...
-
New Guidelines for Managing Sickle Cell Disease Presented at ACP Internal Medicine MeetingNew guidelines for therapeutic strategie...
-
Possible Cure for Sickle Cell Found in ParisHematologists, sickle cell patients, and...
-
Research Team Recognized for Organ-on-a-Chip DesignSCD is a group of genetic disorders that...
-
Screening for sickle cell and beta thalassaemiaSickle cell and beta thalassaemi...
-
Hydroxyurea Treatment in Men with SCA Leads to Drop in Total Sperm Count, Study ShowsResearchers found that treatment with hy...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.